|
Check cap Ltd (NASDAQ: CHEK) |
|
Check cap Ltd
CHEK's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Check Cap Ltd 's sales fell
in the fourth quarter of 2023 from the same quarter a year ago.
Medical Laboratories industry recorded
deterioration of revenues by -7.05 %
Check Cap Ltd 's net profit decreased by -8.06 % in fourth quarter of 2023 year on year, to $18 millions.
• More on CHEK's Growth
|
|
Check Cap Ltd current PE on trailing twelve month basis is above Medical Laboratories industry average.
Company is currently trading with Price to Cash flow multiple of 0.98 in trailing twelve-month period. |
Company |
0.25 |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Medical Laboratories industry's Price to Sales ratio is at 2.26.
• More on CHEK's Valuation
|
|
|
|
|
Check Cap Ltd current PE on trailing twelve month basis is above Medical Laboratories industry average.
Company is currently trading with Price to Cash flow multiple of 0.98 in trailing twelve-month period. |
Company |
0.25 |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Medical Laboratories industry's Price to Sales ratio is at 2.26.
Check Cap Ltd Price to Book Ratio is at 0.18 lower than Industry Avg. of 328.81. and higher than S&P 500 Avg. of 0.01
• More on CHEK's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com